1. Home
  2. CRUS vs IBRX Comparison

CRUS vs IBRX Comparison

Compare CRUS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cirrus Logic Inc.

CRUS

Cirrus Logic Inc.

HOLD

Current Price

$139.18

Market Cap

7.0B

Sector

Technology

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.07

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRUS
IBRX
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
7.2B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
CRUS
IBRX
Price
$139.18
$8.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$157.00
$12.57
AVG Volume (30 Days)
549.9K
12.2M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
30.83
38.71
EPS
7.85
N/A
Revenue
$1,997,379,000.00
$113,288,000.00
Revenue This Year
$7.12
$88.59
Revenue Next Year
$0.49
$131.15
P/E Ratio
$17.43
N/A
Revenue Growth
5.34
668.31
52 Week Low
$92.02
$1.95
52 Week High
$180.42
$12.43

Technical Indicators

Market Signals
Indicator
CRUS
IBRX
Relative Strength Index (RSI) 36.26 51.48
Support Level $127.59 $7.77
Resistance Level $146.81 $8.54
Average True Range (ATR) 4.60 0.56
MACD -0.51 -0.12
Stochastic Oscillator 26.65 34.83

Price Performance

Historical Comparison
CRUS
IBRX

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a supplier of low-power, low-latency, high-precision audio components that are used in a variety of applications, including smartphones, PCs, tablets, AR/VR headsets, wearables, home theater systems, automotive entertainment systems, and professional audio systems. The firm's products are organized into two streams: audio products and HPMS Products. These products include amplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters, and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, India, South Korea, and countries across the world.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: